Clinical Efficacy of Smartphone App–Based Pulmonary Rehabilitation in Chronic Respiratory Diseases: Randomized Controlled and Feasibility Trials
Journal of Medical Internet Research · 2025
DOI: 10.2196/76801 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Medical Internet Research, 2025. Verfasst von Chiwook Chung und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Mobile Applications, Smartphone, Pulmonary Disease, Chronic Obstructive. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Pulmonary rehabilitation improves exercise capacity, dyspnea symptoms, quality of life, and even survival in patients with chronic respiratory disease. Center-based pulmonary rehabilitation programs often face barriers, and alternatives to center-based rehabilitation are urgently needed.
Objective
This study aimed to evaluate the clinical efficacy of smartphone app–based pulmonary rehabilitation in patients with chronic respiratory diseases, including chronic obstructive pulmonary disease, interstitial lung disease, and bronchiectasis.
Methods
This randomized controlled trial recruited 90 participants, randomly allocated into intervention (n=60) and control (n=30) groups. The intervention group received a 12-week smartphone app–based rehabilitation program, while the control group received standard outpatient care. The primary outcomes were maximal oxygen consumption via cardiopulmonary exercise test and the chronic obstructive pulmonary disease assessment test (CAT) after a 12-week period. Based on changes in quality-of-life questionnaire index scores, quality-adjusted life years were calculated, and a cost-utility analysis was conducted. A feasibility trial was also conducted in 4 community primary health care clinics.
Results
Of the 70 participants (median age 65.5 years) who completed the follow-up visits, 67 were included in the per-protocol analysis. The intervention group (n=43) showed significant improvements compared with the control group (n=24) in CAT score (median 7.0, IQR 4.0-15.0 vs median 10.0, IQR 6.5-18.5; P=.04), and International Physical Activity Questionnaire score (median 1488.0, IQR 1250.3-3027.8 vs median 1164.0, IQR 618.8-2205.0; P=.04), but not maximal oxygen consumption. Clinical outcomes showed more prominent improvements among participants who were physically active or compliant with rehabilitation programs. In the user experience survey, around 80% (35/43) of participants in the intervention group found the app easy to use, and more than 60% (27/43) reported that it helped improve dyspnea symptoms. The mean total health care costs were US $495 in the control and US $523 in the intervention group, with no notable difference in the quality-adjusted life year distribution. In the feasibility trial, 24 participants completed follow-up visits, showing a significant reduction in CAT score (median 8.5, IQR 6.0-18.0 to median 5.0, IQR 2.0-7.5; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
- Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, Republic of Korea.
- Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
- Maseok Asan Clinic Internal Medicine, Namyangju, Republic of Korea.
- Seoul Comfort Medical Clinic, Goyang, Republic of Korea.
- Good Breath Internal Medicine Clinic, Gunpo, Republic of Korea.
ORCID-Profile: Chiwook Chung, Ah-Ram Kim, Do-Yoon Kang, Sunmok Kim, Jinyoung Oh, Hui Jung Kim, Byongjo Park, Seong Ho Lee, Dongbum Kim, Hee Kwon, Min-Woo Jo, Sei Won Lee
Zitieren
APA
Chung, C., Kim, A. R., Kang, D. Y., Kim, S., Oh, J., Kim, H. J., Park, B., Lee, S. H., Kim, D., Kwon, H., Jo, M. W., & Lee, S. W. (2025). Clinical Efficacy of Smartphone App–Based Pulmonary Rehabilitation in Chronic Respiratory Diseases: Randomized Controlled and Feasibility Trials. Journal of Medical Internet Research. https://doi.org/10.2196/76801
Vancouver
Chung C, Kim AR, Kang DY, Kim S, Oh J, Kim HJ, et al. Clinical Efficacy of Smartphone App–Based Pulmonary Rehabilitation in Chronic Respiratory Diseases: Randomized Controlled and Feasibility Trials. Journal of Medical Internet Research. 2025. doi:10.2196/76801
BibTeX
@article{Chung2025,
author = {Chung, Chiwook and Kim, Ah-Ram and Kang, Do-Yoon and Kim, Sunmok and Oh, Jinyoung and Kim, Hui Jung and Park, Byongjo and Lee, Seong Ho and Kim, Dongbum and Kwon, Hee and Jo, Min-Woo and Lee, Sei Won},
title = {Clinical Efficacy of Smartphone App–Based Pulmonary Rehabilitation in Chronic Respiratory Diseases: Randomized Controlled and Feasibility Trials},
journal = {Journal of Medical Internet Research},
year = {2025},
doi = {10.2196/76801}
}
EUVIMED